India today denied that it had agreed to take legal action against Indian drugs suppliers for violating procedures and supplying sub-standard medicines to Sri Lanka. An Indian High Commission release said that the High Commissioner Ashok Kantha in his meeting with the Sri Lankan Health Minister Maithripala Sirisena had agreed to work out a mechanism to prevent substandard and low quality manufacturers from entering the market by exploiting loopholes in the procedures. The statement said, while the High Commissioner requested for the details of the companies alleged to have violated tender norms, there was no discussion during the meeting on any legal action being taken by the Government of India against Indian suppliers. It said, Kantha told Sirisena that India had a well-established and vibrant pharmaceuticals industry, which was committed to supplying quality drugs at affordable prices. Mr. Kantha informed the Minister that India was additionally implementing a grant assistance project for the supply of medical equipment to the two General Hospitals in Killinochchi and Mullaitivu for which tenders for equipment procurement had already been floated. The issue regarding the creation of an appropriate facility for housing the Bhabhatron Radiotherapy Machine at Hambantota General Hospital for the treatment of cancer was also discussed. The High Commissioner urged early completion of the facility since the machine was ready to be provided to Sri Lanka. India had announced the gift of a Bhabhatron Radiotherapy Machine to the Government of Sri Lanka at the IAEA General Conference held in September 2010.